Infliximab, a chimeric anti-tumor necrosis factor (TNF) antibody, was shown to induce monocyte apoptosis, which could explain its powerful properties in patients with chronically active Crohn’s disease [48]. This evidence concerns the gene TNF and Crohn disease.